Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Domzalski David Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 8,549 shares @ $3.83, valued at $32.7k
07/05/2023 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 981 shares @ $4.1, valued at $4k
06/02/2023 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Granted 2,766 shares @ $3.4563, valued at $9.6k
04/04/2023 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 2,734 shares @ $3.08, valued at $8.4k
01/04/2023 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 10,685 shares @ $0.15, valued at $1.6k
12/02/2022 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Granted 34,705 shares @ $0.1977, valued at $6.9k
10/04/2022 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 10,683 shares @ $0.223, valued at $2.4k
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Paid exercise price by delivering 23,186 shares @ $0.65, valued at $15.1k
03/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2020 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Granted 4,263 shares @ $1.445, valued at $6.2k
10/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/08/2020 4 Domzalski David (President and CEO) has filed a Form 4 on VYNE Therapeutics Inc.
Txns: Bought 75,000 shares @ $1.3809, valued at $103.6k
07/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/08/2020 4 Domzalski David (President and CEO) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Granted 680,000 shares @ $0
Granted 680,000 options @ $1.95, valued at $1.3M
04/07/2020 4 Domzalski David (President and CEO) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Granted 141,901 shares @ $0
Granted 249,588 shares @ $0
Paid exercise price by delivering 11,772 shares @ $1.4, valued at $16.5k
04/02/2020 4 Domzalski David (President and CEO) has filed a Form 4 on Menlo Therapeutics Inc.
Txns: Paid exercise price by delivering 4,456 shares @ $2.68, valued at $11.9k
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/11/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2019 4 Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Granted 9,842 shares @ $2.159, valued at $21.2k
10/02/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2019 4 Domzalski David (CEO) has filed a Form 4 on Foamix Pharmaceuticals Ltd.
Txns: Sold 3,355 shares @ $2.35, valued at $7.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy